ophthalmology-2016_posters-accepted-abstracts

26 / 37

Page 103
Notes:
conferenceseries.com
Ophthalmology 2016
November 21-23, 2016
November 21-23, 2016 Dubai, UAE
10th International Conference on
Clinical & Experimental Ophthalmology
Volume 7 Issue 9 (Suppl) J Clin Exp Ophthalmol
ISSN: 2155-9570 JCEO, an open access journal
Rachel Fletcher, J Clin Exp Ophthalmol 2016, 7:9(Suppl)
Patient perception of dilating eye drops in the eye clinic
Rachel Fletcher
Liverpool School of Tropical Medicine, UK
Background & Aim: Mydriatic drops are commonly used in ophthalmology clinic to aid fundus examination. The risk of mydriatic
drops precipitating glaucoma is low. However, mydriatic drops can have an impact on patients and their experience of ophthalmic
services. Patient centered care should address patients’ expectations. Research into patient perceptions of dilating eye drops is limited.
Patient’s perceptions of dilating eye drops, side effects and the information patients received in clinic was reviewed.
Methods: A printed questionnaire was given to all patients attending clinic (single-centre) for the period of one week (July 2014)
and returned by the patients on leaving the department. The questionnaire assessed patient demographics, patient satisfaction, prior
information given, clinic information and whether patients had driven to clinic.
Results: 162 questionnaires were completed. Overall patients were happy with the way they received information about the dilating
drops and 98% (n=159) reported they would be happy to have the drops again in the future. 82% (n=13) of patients, had been
informed prior to attending clinic that dilating eye drops may be used. But several patients were unsure why the drops were needed
(27%, n= 44) and worryingly, 16% (n= 26) of patients admitted to driving immediately after their appointment. Most patients were
informed of the risks associated with mydriatic drops and the majority of patients felt blurred vision was the most troublesome,
potential side effect (83%, n=134). 72% (n=117) of patients were aware pain may occur and when to seek medical advice, whilst 83%
had been informed of the potential risk of glaucoma following drop instillation.
Conclusion: In sampling just one department, six different data sources were used to inform patients of the potential side effects
of dilating drops. It appeared that a simpler, replicable and more consistent method of consenting patients for mydriatic drops was
required to aid informed, patient consent. The potential side effects of mydriatic drugs did not deter patients from re-attending
clinics. The majority of patients would be happy to receive dilating drops in the future. Increased patient education prior to attending
clinic is needed to ensure the issue of driving is addressed.
Biography
Rachel Fletcher is a Junior Doctor in the UK. She has completed her Medical degree at Peninsula Medical School and is currently pursuing Diploma of Tropical
Medicine at Liverpool School Tropical Medicine.